“…Our finding of higher risk of using antipsychotics for individuals with CLP and CP and increased use of stimulants for male subjects with CP are consistent with our previous study of the same population (Pedersen et al, ), which found increased risk of hospitalization with a diagnosis of schizophrenia‐like disorders for individuals with CLP or CP and with a diagnosis of behavioral and emotional disorders (including hyperkinetic disorder) for male subjects with CP. The increased use of antipsychotics and stimulants among individuals with OC is also in line with reports of an association between nonsyndromic OC and midline brain anomalies in male subjects (Nopoulos et al, ; Weinberg et al, ), which, in other studies, have been associated with schizophrenia, mental retardation, and developmental delay (Nopoulos et al, ; Bodensteiner et al, ; Landin–Romero et al, ). They are also consistent with prior studies reporting increased frequency of CP among patients with schizophrenia (Gourion et al, ) and increased rates of hyperactivity, impulsivity, and inattention among individuals with nonsyndromic OCs (Nopoulos et al, ; Wehby et al, ).…”